SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 117 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6 | -45.5% | 1,964 | 0.0% | 0.00% | – |
Q1 2024 | $11 | -50.0% | 1,964 | -61.6% | 0.00% | – |
Q4 2023 | $22 | +10.0% | 5,114 | -10.2% | 0.00% | – |
Q3 2023 | $20 | -23.1% | 5,698 | 0.0% | 0.00% | – |
Q2 2023 | $26 | 0.0% | 5,698 | 0.0% | 0.00% | – |
Q1 2023 | $26 | -50.9% | 5,698 | -12.6% | 0.00% | – |
Q4 2022 | $53 | -99.8% | 6,521 | +8.4% | 0.00% | – |
Q3 2022 | $33,000 | +13.8% | 6,013 | +8.3% | 0.00% | – |
Q2 2022 | $29,000 | -34.1% | 5,551 | +3.2% | 0.00% | – |
Q1 2022 | $44,000 | – | 5,380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |